Health authorities say that the Centers for Disease Control and Prevention (CDC) is investigating the death of a woman in Oregon and the hospitalization of another woman in Texas after receiving the Johnson & Johnson vaccination.
The CDC consultants will meet today to discuss whether it is safe to continue using the single-dose Johnson & Johnson vaccine, as senior health officials are preparing to give the green light to the vaccine.
Imelda Garcia of the Texas Department of Health said: “It’s important to remember that just because something is reported doesn’t mean it was caused by or related to the vaccine. .”
Health officials in these states said the CDC notified Oregon on Tuesday and Texas on Wednesday.
The State Department of Health said a woman in her fifties in Oregon received help from Johnson & Johnson before the vaccine was suspended. The Oregon Health Administration (OHA) said that within two weeks of the vaccination, she developed a rare but severe blood clot with extremely low platelets.
A Texas Department of Health spokesperson said a Texas woman who received the same vaccine was hospitalized with symptoms similar to six American residents who had recently formed blood clots in the United States. Both countries confirmed that the new case is separate from the first six cases.
The US health agency recommended last week to stop using the Johnson & Johnson vaccine because there are six rare cases of blood clots in approximately 7 million people. The European Medicines Agency (EMA) said on Tuesday that there may be a link between the Johnson & Johnson vaccine and rare blood clots in adults receiving the vaccine in the United States, but added that the benefits of the vaccine outweigh the risks.